GKB Ophthalmics Statistics
Total Valuation
GKB Ophthalmics has a market cap or net worth of INR 312.52 million. The enterprise value is 400.65 million.
| Market Cap | 312.52M |
| Enterprise Value | 400.65M |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GKB Ophthalmics has 5.04 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 5.04M |
| Shares Outstanding | 5.04M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 66.13% |
| Owned by Institutions (%) | 4.02% |
| Float | 1.23M |
Valuation Ratios
The trailing PE ratio is 25.62.
| PE Ratio | 25.62 |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.68, with an EV/FCF ratio of -8.29.
| EV / Earnings | 32.88 |
| EV / Sales | 0.27 |
| EV / EBITDA | 4.68 |
| EV / EBIT | 7.53 |
| EV / FCF | -8.29 |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.52 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | -2.41 |
| Interest Coverage | 2.01 |
Financial Efficiency
Return on equity (ROE) is 5.44% and return on invested capital (ROIC) is 12.38%.
| Return on Equity (ROE) | 5.44% |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 12.38% |
| Return on Capital Employed (ROCE) | 8.83% |
| Weighted Average Cost of Capital (WACC) | 11.11% |
| Revenue Per Employee | 8.77M |
| Profits Per Employee | 71,676 |
| Employee Count | 170 |
| Asset Turnover | 1.16 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, GKB Ophthalmics has paid 766,000 in taxes.
| Income Tax | 766,000 |
| Effective Tax Rate | 2.47% |
Stock Price Statistics
The stock price has decreased by -13.52% in the last 52 weeks. The beta is 0.48, so GKB Ophthalmics's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -13.52% |
| 50-Day Moving Average | 64.62 |
| 200-Day Moving Average | 62.63 |
| Relative Strength Index (RSI) | 44.50 |
| Average Volume (20 Days) | 1,508 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GKB Ophthalmics had revenue of INR 1.49 billion and earned 12.19 million in profits. Earnings per share was 2.42.
| Revenue | 1.49B |
| Gross Profit | 436.67M |
| Operating Income | 53.82M |
| Pretax Income | 31.04M |
| Net Income | 12.19M |
| EBITDA | 86.19M |
| EBIT | 53.82M |
| Earnings Per Share (EPS) | 2.42 |
Balance Sheet
The company has 48.97 million in cash and 116.55 million in debt, with a net cash position of -67.59 million or -13.41 per share.
| Cash & Cash Equivalents | 48.97M |
| Total Debt | 116.55M |
| Net Cash | -67.59M |
| Net Cash Per Share | -13.41 |
| Equity (Book Value) | 548.88M |
| Book Value Per Share | 103.81 |
| Working Capital | 367.73M |
Cash Flow
In the last 12 months, operating cash flow was -38.07 million and capital expenditures -10.27 million, giving a free cash flow of -48.34 million.
| Operating Cash Flow | -38.07M |
| Capital Expenditures | -10.27M |
| Depreciation & Amortization | 32.37M |
| Net Borrowing | -28.41M |
| Free Cash Flow | -48.34M |
| FCF Per Share | -9.59 |
Margins
Gross margin is 29.29%, with operating and profit margins of 3.61% and 0.82%.
| Gross Margin | 29.29% |
| Operating Margin | 3.61% |
| Pretax Margin | 2.08% |
| Profit Margin | 0.82% |
| EBITDA Margin | 5.78% |
| EBIT Margin | 3.61% |
| FCF Margin | n/a |
Dividends & Yields
GKB Ophthalmics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.12% |
| Shareholder Yield | 0.12% |
| Earnings Yield | 3.90% |
| FCF Yield | -15.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |